{"id":"NCT00697073","sponsor":"Santhera Pharmaceuticals","briefTitle":"Study to Assess the Safety and Tolerability of Idebenone in the Treatment of Friedreich's Ataxia Patients","officialTitle":"A Phase III Open-Label, Single Group Extension Study of the Safety and Tolerability of Idebenone in the Treatment of Friedreich's Ataxia Patients","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-07","primaryCompletion":"2010-05","completion":"2010-05","firstPosted":"2008-06-13","resultsPosted":"2011-08-04","lastUpdate":"2023-07-11"},"enrollment":68,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Friedreich's Ataxia"],"interventions":[{"type":"DRUG","name":"Idebenone","otherNames":[]}],"arms":[{"label":"1","type":"EXPERIMENTAL"}],"summary":"This study is meant to assess the safety and tolerability of idebenone in patients with Friedreich's Ataxia over a 12 months period.","primaryOutcome":{"measure":"Change in ICARS","timeFrame":"baseline and 12 months","effectByArm":[{"arm":"High Dose Idebenone","deltaMin":1.1,"sd":5.64}],"pValues":[]},"eligibility":{"minAge":"8 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":6},"locations":{"siteCount":2,"countries":["United States"]},"refs":{"pmids":["21779958"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":4,"n":68},"commonTop":["headache","upper respiratory tract infection","nausea","pyrexia"]}}